SEC Form 4 · accession 0000059478-17-000146
ELI LILLY & Co · LLY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christi Shaw
Officer — SVP and Pres., Lilly Bio-Meds
Period of report
May 1, 2017
Accepted (ET)
May 8, 2017 · 3:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000059478
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF1,F2 | — | May 1, 2017 | A | 27,500 | A | — | — | Common Stock | 27,500 | 27,500 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
- F2The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019.